Conclusion: RIF was common in breast cancer patients receiving post-operative RT and TJ-41 was effective for the RIF patients and improved their quality of life. However, these results may lack objectivity and the study was conducted with no placebo group. Improvement in objectivity of the assessment and a comparative study will be needed. Purpose or Objective: Hyperthermia is a powerful radiosensitizer for treatment of superficial tumors. Several trials showed an advantage of combining radiotherapy with hyperthermia in terms of both local tumor control and overall survival. The purpose of this study is to evaluate both efficacy and toxicity of radiotherapy-hyperthermia (RT-HT) in the treatment of superficial recurrent and metastatic tumors in patients previously or not previously irradiated.
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Material and Methods:
In our Institution twenty-three patients (mean age 71,4 years; range: 51-88) with histologically confirmed superficial recurrent/metastatic tumors were enrolled: 11 breast carcinoma, 6 head&neck cancer, 2 malignant melanoma, 2 sarcomas, 1 uterine adenocarcinoma and 1 hepatocarcinoma. Patients underwent radiotherapy treatment using 3D-conformal radiotherapy (8/23) or Helical Tomotherapy (15/23). External beam radiotherapy was delivered in 6-27 fractions of 1.8-5 Gy for a total dose of 20-57.5 Gy (mean external dose: 41 Gy). Prescribed dose was established taken into account, of the previous radiation doses, in previously irradiated patients, Karnofsky performance status and patient compliance. Hyperthermia treatment was performed with an electromagnetic superficial applicator operating at the frequency of 434 MHz. HT session was delivered once/twice weekly during the period of external radiotherapy, 1-2 hours after radiotherapy, to a mean total of 5 treatments [range: 1-9 sessions]. Termocouples were used to evaluate temperature distribution map. Average, maximum and minimum temperature parameters were recorded during hyperthermia treatment. The treatment goal was to reach 40-42°C in > 90% (T90) of measured points for a duration of 60 minutes. Acute and late toxicity was evaluated according to the CTCAE criteria. Local control was assessed after the end of the treatment on the basis of the RECIST Criteria.
Results: During hyperthermia treatment the median temperature reached was 40.5 °C [range: 39 -42.9°C]. During the radiotherapy in association with hyperthermia 2 pts (10%) had G3 toxicity and one of these interrupted the treatment. One pt had acute cutaneous toxicity ≥ G3 at 1 month. No pts had toxicity ≥ G2 at 3 and 6 months. No toxicity was observed at 12 months. The mean follow-up was 10 months (range 3-22 months). Four pts (17%) had a complete response (CR), 11 pts ( 48%) had a partial response (PR),7 pts (30%) had a stable disease, (SD) and only 1 pt (4%) had progression disease (PD) and subsequently died. The Local control rate was 95%. Univariate analysis showed that Tmean,Tmax, Tmin,T90 parameters were not associated with local control rate.
Conclusion:
Radio-hyperthermia can result in an effective approach, particularly in previously irradiated patients or in radio-resistant tumors. Our results show that RadioHyperthermia is an useful combined treatment with a good local control rate and a very high patient compliance.
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